Literature DB >> 12754507

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Hideo Yasukawa1, Masanobu Ohishi, Hiroyuki Mori, Masaaki Murakami, Takatoshi Chinen, Daisuke Aki, Toshikatsu Hanada, Kiyoshi Takeda, Shizuo Akira, Masahiko Hoshijima, Toshio Hirano, Kenneth R Chien, Akihiko Yoshimura.   

Abstract

Whereas interleukin-6 (IL-6) is a proinflammatory cytokine, IL-10 is an anti-inflammatory cytokine. Although signal transducer and activator of transcription 3 (STAT3) is essential for the function of both IL-6 and IL-10, it is unclear how these two cytokines have such opposing functions. Here we show that suppressor of cytokine signaling 3 (SOCS3) is a key regulator of the divergent action of these two cytokines. In macrophages lacking the Socs3 gene or carrying a mutation of the SOCS3-binding site in gp130, the lipopolysaccharide-induced production of tumor necrosis factor (TNF) and IL-12 is suppressed by both IL-10 and IL-6. SOCS3 specifically prevents activation of STAT3 by IL-6 but not IL-10. Taken together, these data indicate that SOCS3 selectively blocks signaling by IL-6, thereby preventing its ability to inhibit LPS signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754507     DOI: 10.1038/ni938

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  272 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

2.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

3.  TCA cycle inactivation in Staphylococcus aureus alters nitric oxide production in RAW 264.7 cells.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Donald J Gardner; James M Musser; David Steffen; Greg A Somerville; Jay Reddy
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

Review 4.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

5.  Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis.

Authors:  DeAnna A Baker; Jeremy Barth; Raymond Chang; Lina M Obeid; Gary S Gilkeson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

Review 6.  Müller cells and diabetic retinopathy.

Authors:  Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal:  Vision Res       Date:  2017-09-05       Impact factor: 1.886

7.  Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Authors:  Yan Ke; Ke Liu; Guo-Qiang Huang; Yan Cui; Henry J Kaplan; Hui Shao; Deming Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Molecular markers of preterm labor in the choriodecidua.

Authors:  Renu Shankar; Matthew P Johnson; Nicholas A Williamson; Fiona Cullinane; Anthony W Purcell; Eric K Moses; Shaun P Brennecke
Journal:  Reprod Sci       Date:  2009-12-15       Impact factor: 3.060

9.  Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight.

Authors:  Ren Zhang; Harveen Dhillon; Huali Yin; Akihiko Yoshimura; Bradford B Lowell; Eleftheria Maratos-Flier; Jeffrey S Flier
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

10.  Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.

Authors:  Chunguang Yan; Peter A Ward; Ximo Wang; Hongwei Gao
Journal:  FASEB J       Date:  2013-04-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.